Skip to main content
. 2022 May 12;24(12):2200–2209. doi: 10.1093/neuonc/noac124

Table 1.

Clinical and treatment characteristics

Variable N
Age
 Diagnosis 7.77 years (1.29–17.52)
 At start of radiation therapy 8.98 years (3.20–17.63)
Presentation
 Headache 62
 Visual disturbance 17
 Growth delay 9
 Emesis 4
 Loss of consciousness 4
 Head injury 3
 Precocious puberty 2
Gender
 Female 46
 Male 55
Race
 Asian/Pacific islander 1
 Black 22
 Hispanic 2
 White 76
Extraventricular drain
 Yes 23
 No 78
CSF shunt
 Yes 27
 No 74
CTV margin
 ≤0.5 cm 76
 1.0 cm 25
PTV margin
 0.3 cm 58
 0.5 cm 43
Dose
 54Gy 94
 55.8Gy 7
Target volumes (mL)
 GTV 12.28(0.42–64.66)
 CTV 36.84 (5.20–176.7)
 PTV 65.75 (17.31–257.5)
Target volume dose coverage (cGy)
 D95GTV 5441 (5298–5740)
 D95CTV 5415 (5031–5701)
 D95PTV 5364 (5347–5691)
Planning and delivery method
 Conformal radiation therapy 84
 Intensity-modulated radiation therapy 17

Abbreviations: CSF, cerebrospinal fluid; CTV, clinical target volume; PTV, planning target volume; GTV, gross total volume.